Patents by Inventor Marcin DULEBA

Marcin DULEBA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220202792
    Abstract: The present disclosure provides methods and formulations for treating a patient suffering from one or more of chronic inflammatory injury, metaplasia, dysplasia or cancer of an epithelial tissue, which method comprises administering to the patient an agent that selectively kills or inhibits the proliferation or differentiation of pathogenic epithelial stem cells (PESCs) relative to normal epithelial stem cells in the tissue in which the PESCs are found. Representative epithelial tissues include pulmonary, genitourinary, gastrointestinal/esophageal, pancreatic and hepatic tissues.
    Type: Application
    Filed: April 24, 2020
    Publication date: June 30, 2022
    Applicants: University of Houston System, The Board of Regents of The University of Texas System, Tract Pharmaceuticals, Inc.
    Inventors: Frank McKEON, Marcin DULEBA, Yanting ZHANG, Jingzhong XIE, Wa XIAN, Matthew VINCENT
  • Publication number: 20210062145
    Abstract: The present invention relates to a culture media system that is useful for the isolation and epigenetically stable propagation of normal stem cells in culture which are derived from columnar epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.
    Type: Application
    Filed: December 28, 2018
    Publication date: March 4, 2021
    Applicants: University of Houston System, Tract Pharmaceuticals, Inc.
    Inventors: Wa XIAN, Frank McKEON, Marcin DULEBA, Matthew P. VINCENT